期刊档案 · Medicine-Oncology

Acta Haematologica Polonica

ISSN 0001-5814 · eISSN 2300-7117 · Walter de Gruyter

Acta Haematologica Polonica 影响因子 0.6(官网公布),钻石开放获取(无 APC),免版面费,2025 年发文 89 篇,ESCI、Scopus 收录。

影响因子0.6期刊官网公布的最新值
中科院分区—未被分区表收录
审稿周期—暂无反馈
版面费免版面费钻石开放获取(无 APC)
录用比例—暂无反馈
年发文量89 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Acta Haematologica Polonica 由 Walter de Gruyter 出版。按 OpenAlex 近年发文统计,该刊主要发表 Chronic Lymphocytic Leukemia Research、Lymphoma Diagnosis and Treatment、Immunodeficiency and Autoimmune Disorders 等主题的论文,这 3 个主题约占 29.8%,主导子领域为 Hematology。(根据 OpenAlex 主题统计与中科院分区数据生成)

“Acta Haematologica Polonica” (AHP) is a peer-reviewed, English language, gold open-access journal. It is the official bimonthly of the Polish Society of Haematologists and Transfusiologists as well as the Institute of Haematology and Transfusion Medicine. The Journal has been associated with haematology and transfusion since 1970. AHP publishes original research articles, clinical vignettes, and reviews. "Acta Haematologica Polonica" covers areas of physiology and pathology in hematology and transfusion medicine, among other leucocytes, erythrocytes, platelets, immune system, mechanisms of hemostasis and clinical aspects of haematological malignancies. Journal publishes: original studies, reviews, expert guidelines, short communications, clinical vignettes, letters to the Editor, and editorials.

摘自期刊官网 Aims & Scope

研究方向(LetPub):Medicine-Oncology

主编 Bartosz Puła出版商官网

编委会国家分布:未见中国大陆编委;主要国家 波兰 35、美国 4、德国 3、英国 2、瑞典 2(共 50 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Chronic Lymphocytic Leukemia ResearchMedicine14.5%
  2. Lymphoma Diagnosis and TreatmentMedicine8.5%
  3. Immunodeficiency and Autoimmune DisordersImmunology and Microbiology6.9%
  4. Chronic Myeloid Leukemia TreatmentsMedicine6.3%
  5. Acute Lymphoblastic Leukemia researchMedicine5.6%
  6. Multiple Myeloma Research and TreatmentsMedicine5.4%
  7. Acute Myeloid Leukemia ResearchMedicine4.9%
  8. Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine4.7%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

ESCIScopusDOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

Google Scholar、EBSCO、CNKI、J-Gate、OCLC、Crossref、Arianta、Biosis Previews (WoS)、CNKI (China National Knowledge Index)、Index Copernicus、Polish Medical Library (GBL)、SJR (Scimago Journal & Country Rank)、WorldCat (OCLC)出版商官网

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

影响因子(出版商公布)
0.6出版商官网 ·
CiteScore 2026-06
1.2LetPub ·
CiteScore(出版商公布)
1.2出版商官网 ·
SJR 2026-06
0.16LetPub ·
SNIP 2026-06
0.24LetPub ·
h-index
14OpenAlex ·
i10-index
27OpenAlex ·
两年平均被引
0.39OpenAlex ·
自引率
33.3%LetPub ·
Gold OA 文章占比
95.77%LetPub ·

发文规模

年文章数
47LetPub ·

逐年发文量 OpenAlex 统计 · 累计 1,390 篇 · 当年数据不完整

年份发文量其中 OA被引
202654542
2025898931
2024585845
2023767684
20226363129
20219797280

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

投稿到发表(期刊自报)
约 14 周DOAJ ·
评审方式
双盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

钻石开放获取(无 APC)DOAJ

所有文章开放获取,且不向作者收取文章处理费。

来源文章处理费费用减免许可证观测时间
DOAJ无文章处理费无CC BY-NC-ND

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点3 项,摘自作者指南
参考文献格式
Vancouver 格式
推荐审稿人
必须提供 2 位
投稿信(Cover letter)
必须提供
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型7 种,含篇幅限制
  1. case reportAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…正文 ≤ 2,000 词
  2. editorialAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…未说明篇幅
  3. letter to the editorAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…未说明篇幅
  4. original research articleAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…未说明篇幅
  5. reviewfield and identify future implications. Reviews should not exceed 5000 words, 10 figures or tables, and 100 references. They should cont正文 ≤ 5,000 词
  6. review articleAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…未说明篇幅
  7. short communicationAccepted papers are published in the following journal sections: Original research article, Review article, Editorial, Expert guidelines, Short communication, L…未说明篇幅
出版商官网
官网政策摘录作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、查重、自存档
作者资格 Changes to authorship

作者应在投稿前仔细考虑作者名单及其顺序,并在首次投稿时提供最终作者名单;只有在稿件被接受之前且经期刊编辑批准,才可增删或调整作者姓名,申请变更时通讯作者须向编辑提供变更理由及全体作者的书面同意。 模型中文摘要

Authors are expected to carefully consider the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, …

原文 ↗出版商官网 ·
利益冲突 Declaration of conflict of interest

所有作者必须披露可能不当影响其工作的财务和个人关系,并须在两处披露利益:一是利益声明的摘要声明(双盲时置于标题页文件,单盲时置于稿件文件,无利益可声明时写“Declarations of interest: none”),二是作为期刊官方记录一部分的单独利益声明表。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/ registrations, and grants or other funding. Authors must disclose any interests in two plac…

原文 ↗出版商官网 ·
数据可用性

作者应说明所投稿件底层数据是否可供其他研究者获取。 模型中文摘要

Authors should indicate whether the source data underlying the submitted manuscript are available to other researchers.

原文 ↗出版商官网 ·
出版伦理

期刊出版方和编辑强烈建议期刊编辑、作者和读者遵循出版伦理委员会(COPE)的原则,特别是在处理伦理不端行为时。 模型中文摘要

Publisher and Editors of the Journal strongly recommends that journal editors, authors and readers adhere to the principles of the Committee on Publication Ethics (COPE), particularly in dealing with ethical misconduct.

原文 ↗出版商官网 ·
许可与版权 Copyright Notice

在线提交表单的电子填写(作者声明)等同于在稿件被接受的前提下,将所提交材料的出版权和传播权版权自动转让给版权所有者(波兰血液学与输血学会、血液与输血医学研究所),且作者未经Via Medica事先书面同意不得在其他任何地方以任何语言发表其数据或图表。 模型中文摘要

Completion of the online submission form electronically (the Author's Statement) is tantamount to automatic transfer of the copyright for publishing and distribution of the submitted material (in all current and future forms and fields of exploitation) to the Copyright Owner, i.e., Polish Society Haematology and Blood Transfusion, Institute of Haematology and Transfusion Medicine, on condition tha…

原文 ↗出版商官网 ·
开放获取 Open Access Policy

《Acta Haematologica Polonica》所有文章均以开放获取形式提供,并按知识共享署名-非商业性-禁止演绎4.0国际许可(CC BY-NC-ND 4.0)发表,允许下载和分享文章但须注明作者和出版方,且不得以任何方式更改或商业使用。 模型中文摘要

All articles published in “Acta Haematologica Polonica” are available in open access formula and are published under Creative Common Attribution-Non Commercial-No Derivatives 4.0, International Licence (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commerci…

原文 ↗出版商官网 ·
同行评审 REVIEW PROCESS

稿件须基于其对所研究主题提出新见解、并可能促进研究进展或改变临床实践或对疾病的认识来评估,且稿件所列全体作者均须同意投稿,通讯作者在投稿信上的签名即表明这些条件已满足。 模型中文摘要

Manuscripts are evaluated on the basis that they present new insights into the investigated topic and are likely to contribute to a research progress or change in clinical practice or in thinking about a disease. It is understood that all authors listed on a manuscript have agreed to its submission. The signature of the corresponding author on the letter of submission signifies that these conditio…

原文 ↗出版商官网 ·
查重 Preventing Plagiarism

为排除甚至无意的抄袭,该期刊引入了Ithenticate软件,所有被接受发表的论文都会在稿件系统内自动进行相似度筛查,编辑也可在评审或发表后任何其他时点决定运行相似度报告,对可疑报告将逐一单独处理。 模型中文摘要

To exclude even unintentional plagiarism, “Acta Haematologica Polonica” (AHP) has introduced Ithenticate software, widely known in the academic community. All papers accepted for publication are now automatically screened within the manuscript system. Additionally, Editors may decide to run a similarity report at any other point during the review process or post-publication. Our Editorial team is …

原文 ↗出版商官网 ·
自存档 Self-archiving Policy

出版方Via Medica的自存档政策规定,作者只能将已接受的稿件(包括最终PDF版本和/或“印刷前”版本)存入任何知识库,且须注明原始出版来源并插入指向Via Medica网站上已发表文章的链接,同时提供完整的书目信息。 模型中文摘要

Via Medica (Publisher) self-archiving policy establishes that authors can archive only accepted manuscripts, including the final PDF version and/or ‘ahead of print’ in any repository. In details, the author may only post their version provided acknowledgment is given to the original source of publication, and a link is inserted to the published article on Via Medica (Publisher) website. Apart from…

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Walter de Gruyter
ISSN
0001-5814
电子版 ISSN
2300-7117
学会 / 主办单位
Polish Society of Haematologists and Transfusiologists and the Insitute of Haematology and Transfusion Medicine
官网最新一期
Volume 57, Issue 4(2026 年)
官方链接

常见问题

关于 Acta Haematologica Polonica 的常见问题

Acta Haematologica Polonica 的影响因子是多少?

期刊官网公布的影响因子为 0.6,属期刊自述数据,LetPub 暂无该刊的影响因子记录,CiteScore 为 1.2,h-index 为 14。

Acta Haematologica Polonica 的投稿格式要求是什么?

据期刊作者指南:参考文献格式:Vancouver 格式;推荐审稿人:必须提供 2 位;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Acta Haematologica Polonica 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 50 位编委中,没有中国大陆学者;人数最多的国家是 波兰(35 位)、美国(4 位)、德国(3 位)。统计按编委会页面列出的机构国家计,仅供参考。

Acta Haematologica Polonica 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Acta Haematologica Polonica 被 ESCI、Scopus、DOAJ 收录。

Acta Haematologica Polonica 是开放获取期刊吗?版面费多少?

Acta Haematologica Polonica 为钻石开放获取(无 APC)。不收取文章处理费。

来源与更新

本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。